AVADEL PHARMACEUTICALS PLC Quarterly Entity Common Stock, Shares Outstanding from Q4 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Avadel Pharmaceuticals Plc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2011 to Q3 2024.
  • Avadel Pharmaceuticals Plc Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 96.4M shares, a 7.3% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 96.4M +6.56M +7.3% Nov 8, 2024 10-Q 2024-11-12
Q2 2024 96.3M +6.9M +7.72% Aug 5, 2024 10-Q 2024-08-08
Q1 2024 96.1M +31.6M +49.1% Apr 24, 2024 10-K/A 2024-04-26
Q3 2023 89.8M +28M +45.4% Nov 6, 2023 10-Q 2023-11-08
Q2 2023 89.4M +29.6M +49.5% Aug 4, 2023 10-Q 2023-08-09
Q1 2023 64.5M +5.45M +9.22% Mar 23, 2023 10-K 2023-03-29
Q3 2022 61.8M +3.16M +5.39% Nov 7, 2022 10-Q 2022-11-09
Q2 2022 59.8M +1.2M +2.04% Aug 4, 2022 10-Q 2022-08-09
Q1 2022 59M +567K +0.97% Mar 11, 2022 10-K 2022-03-16
Q3 2021 58.6M +347K +0.6% Nov 4, 2021 10-Q 2021-11-08
Q2 2021 58.6M +376K +0.65% Aug 5, 2021 10-Q 2021-08-09
Q1 2021 58.5M +12.1M +26% Mar 4, 2021 10-K 2021-03-09
Q3 2020 58.3M +20.8M +55.6% Nov 5, 2020 10-Q 2020-11-09
Q2 2020 58.2M +20.8M +55.5% Aug 6, 2020 10-Q 2020-08-10
Q1 2020 46.4M +9.05M +24.2% Mar 10, 2020 10-K 2020-03-16
Q3 2019 37.5M +438K +1.18% Nov 8, 2019 10-Q 2019-11-12
Q2 2019 37.5M +686K +1.87% Aug 6, 2019 10-Q 2019-08-09
Q1 2019 37.4M -597K -1.57% Mar 13, 2019 10-K 2019-03-15
Q3 2018 37M -2.75M -6.92% Nov 2, 2018 10-Q 2018-11-05
Q2 2018 36.8M -3.32M -8.28% Aug 2, 2018 10-Q 2018-08-07
Q1 2018 38M -3.43M -8.28% Mar 9, 2018 10-K 2018-03-16
Q3 2017 39.8M -1.48M -3.59% Nov 2, 2017 10-Q 2017-11-09
Q2 2017 40.1M -1.16M -2.81% Aug 2, 2017 10-Q 2017-08-09
Q1 2017 41.4M +138K +0.34% Mar 20, 2017 10-K 2017-03-28
Q3 2016 41.2M Nov 7, 2016 10-Q 2016-11-14
Q2 2016 41.2M +742K +1.83% Aug 3, 2016 10-Q 2016-08-15
Q1 2016 41.2M +988K +2.46% Mar 31, 2016 10-Q 2016-05-10
Q2 2015 40.5M +1.92M +4.97% Jun 30, 2015 6-K 2015-12-31
Q1 2015 40.3M +1.99M +5.19% Mar 31, 2015 6-K 2015-07-10
Q4 2014 40.2M +14.6M +56.9% Dec 31, 2014 20-F/A 2015-10-01
Q3 2014 38.9M +38.9M Sep 30, 2014 6-K 2014-11-17
Q2 2014 38.6M +13.1M +51.5% Jun 30, 2014 6-K 2014-08-08
Q1 2014 38.3M Mar 31, 2014 6-K 2014-07-08
Q4 2013 25.6M +650K +2.61% Dec 31, 2013 20-F/A 2014-04-30
Q3 2013 0 Sep 30, 2013 6-K 2014-01-15
Q2 2013 25.5M +308K +1.23% Jun 30, 2013 6-K 2013-12-06
Q4 2012 25M 0 0% Dec 31, 2012 20-F 2013-04-30
Q2 2012 25.2M Jun 30, 2012 6-K 2012-12-14
Q1 2012 25.2M Mar 31, 2012 6-K 2012-09-13
Q4 2011 25M Dec 31, 2011 20-F 2012-04-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.